PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12163380-10	2002	These lines up-regulate MUC2 expression in response to both methylation inhibition by 5-azacytidine and exposure to Pseudomonas aeruginosa lipopolysaccharide, both of whose effects can be suppressed by genistein pretreatment.	Azacitidine	86-99	mucin 2, oligomeric mucus/gel-forming	Homo sapiens	24-28	
16721789-5	2006	To investigate the histone modification and DNA methylation of the promoter region of the MUC2 gene, we treated 2 human pancreatic cancer cell lines, PANC1 (MUC2-negative) and BxPC3 (MUC2-positive) with the DNA methyltransferase inhibitor 5-azacytidine (5-aza), the histone deacetylase inhibitor trichostatin A (TSA), and a combination of these agents.	Azacitidine	239-252	mucin 2, oligomeric mucus/gel-forming	Homo sapiens	90-94	
16721789-5	2006	To investigate the histone modification and DNA methylation of the promoter region of the MUC2 gene, we treated 2 human pancreatic cancer cell lines, PANC1 (MUC2-negative) and BxPC3 (MUC2-positive) with the DNA methyltransferase inhibitor 5-azacytidine (5-aza), the histone deacetylase inhibitor trichostatin A (TSA), and a combination of these agents.	Azacitidine	239-244	mucin 2, oligomeric mucus/gel-forming	Homo sapiens	90-94	
16721789-7	2006	The expression level of MUC2 mRNA in PANC1 cells exhibited a definite increase when treated with TSA and 5-aza/TSA, whereas 5-aza alone induced only a slight increase.	Azacitidine	105-110	mucin 2, oligomeric mucus/gel-forming	Homo sapiens	24-28